CClinicalTrials.gg
Status unknownNCT05785572Updated Apr 7, 2023

Effect of Radiofrequency of Suprascapular Nerve in Shoulder Reverse Arthroplasty

An interventional study of supraescapular nerve radiofrequency and interescalenic braquial plexus in Rotator Cuff Tear Arthropathy and Post Operative Pain, sponsored by Hospital Universitario Virgen Macarena. Status unknown at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-04-07.

Sponsored by Hospital Universitario Virgen Macarena · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jun 2022), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Jul 2021, registered Mar 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpuse of this study is to asses if the pulsed radiofrecuency of the supraescapular nerve and accesory nerve have the same or superior efectivity controlling the acute postoperative pain than interscalenic braquial plexus block

Read the detailed description

This is a randomized, double-blind trial that compares the effect in postoperative pain of pulsed radiofrecuency of the supraescapular nerve carried out at least two to four weeks before reverse total shoulder arthroplasty surgery with interscalenic braquial plexus block done at the moment of the surgery. All the patients received conventional general anaesthesia and multimodal postoperative analgesia with additional patient-controlled rescue analgesics were prescribed

02

Conditions studied

  • Rotator Cuff Tear Arthropathy
  • Post Operative Pain

Keywords

  • rotator cuff arthropathy
  • reverse shoulder arthroplasty
  • supraescapular nerve radiofrecuency
  • post operative pain
03

In context

Joint Diseases

712 studies on the registry are indexed under Joint Diseases; 127 are open to participants now.

This study's planned enrollment of 54 is close to the median of 60 across 470 interventional studies indexed under Joint Diseases.

Browse Joint Diseases studies →

Lead sponsor

Hospital Universitario Virgen Macarena is the lead sponsor of 18 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Over 18 y.o.
  • Cronic pain (more than 3 months) due to rotator cuff arthropathy
  • VAS higher than 4
  • Decrease Constant score
  • Conservative treatment (physiotherapy and NSAIs) unsuccessful

Exclusion criteria

Exclusion criteria:

  • psychiatric illness
  • drug abuse.
  • previous surgeries.
  • acute traumatic pathology or ethiology different from rotator cuff arthropathy
  • pacemaker
  • infectious process
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
54 participants (estimated)

Study arms

  • Experimental
    Radiofrequency group

    Patient group that undergoes Radiofrequency of supraescapular nerve before shoulder arthroplasty surgery

    Procedure: supraescapular nerve radiofrequency

  • Active comparator
    Interscalenic braquial plexus block group

    Interscalenic braquial plexus block done at the moment of the surgery.

    Procedure: interescalenic braquial plexus

Interventions

  • Proceduresupraescapular nerve radiofrequency

    supraescapular nerve radiofrequency or interescalenic braquial plexus for pain control in shoulder arthroplasty surgery

  • Procedureinterescalenic braquial plexus

    supraescapular nerve radiofrequency or interescalenic braquial plexus for pain control in shoulder arthroplasty surgery

06

What researchers measure

Primary outcomes

  1. Visual analogical scale

    Postoperative acute pain measurement. From 0 to 10, Zero means no pain and ten would be the worse pain that the paitient could feel.

    Time frame: periodical measurements of pain, inmediate preoperative pain up to three months postoperative

Secondary outcomes

  1. Visual analogical scale

    chronic pain after surgery. From 0 to 10, Zero means no pain and ten would be the worse pain that the paitient could feel.

    Time frame: 3 months postop. until 1 year postop

07

Study locations

1 of 1 sites recruiting
  • Hospital Universitario Virgen Macarena
    Sevilla, 41009, Spain
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 7, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05785572
Lead sponsor
Hospital Universitario Virgen Macarena
Responsible party
Sponsor
First posted
Mar 27, 2023
Start date
Jul 1, 2021
Primary completion
Jul 1, 2023 (estimated)
Completion
Jul 1, 2024 (estimated)
Last update
Apr 7, 2023

Study contacts

Maria Carmen González López
Contact
mcglez89@gmail.com
0034 675175531
Jesus Manuel García Hernández
Contact
jesusgciahdez@gmail.com
0034 690739292
Jose Manuel Lopez Millan
principal investigator · Hospital Universitario Virgen Macarena

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion